Skip to contents

Thomas Frederick McElrath, MD, PhD
Associate Obstetrician & Gynecologist, Brigham and Women's Hospital
Associate Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School

Brigham and Women's Hospital
Department of Obstetrics and Gynecology
75 Francis Street
Boston, MA 02115

Research Location: Mary Horrigan Connors Center

Edit Profile

Research Narrative:

I am PI on the LIFECODES birth cohort run by the Maternal-Fetal Medicine Division of the BWH. This is one of the largest prospectively collected biobanks for human pregnancy in North America. My personal research areas are divided into to primary interests:

1)  The development of biomarkers to predict adverse pregnancy outcome. Specifically, my work involved  the use of exosome associated proteins sampled at the beginning of gestation to predict the risk of spontaneous preterm birth in the third trimester.

2) The association between environmental exposures and pregnancy complication. Phthalate and other plasticizers are associated with a variety of adverse reproductive outcomes. Using the longitudinal samples and data available in the LIFECODES cohort, our group has been able to refine the effect of these exposures on the risk of preeclampsia, spontaneous preterm birth and intrauterine growth restriction.  

Harvard Medical School, 1996, M.D.
University of Pennsylvania, 1994, Ph.D.

Fulbright Scholar
Excellence in Teaching - Association of Professors of Gynecology and Obstetrics (APGO)
Outstanding Teacher of Obstetrics - Brigham & Women's Department of OB/GYN
Partners Service Award - Brigham & Women's Hospital
Paper of the Year Award 2014 - National Institute of Environmental Health Sciences
Boston Magazine Top Physician 2017 – present

Lab Members:
David Cantonwine, Ph.D.

John Meeker ,PhD, University of Michigan, Phthalates research

Kelly Ferguson ,PhD, NIEHS, Phthalates research

Scott Weiss, MD, Channing Lab, Brigham & Womens, Birth outcomes research

Kevin Rosenblatt MD, PhD, University of Texas Health Science Center at Houston, Biomarker research

Zhen Zhang, PhD, Johns Hopkins, Biomarker research

LIFECODES Longitudinal Birth Cohort

Other Professional Activities:
Scientific Advisory Board, NxPrenatal
Board Examiner, American Board of Obstetrics & Gynecology

Publications (Pulled from Harvard Catalyst Profiles):

1. Sen S, Herlihy M, Hacker M, Mcelrath T, Cherkerzian S, Oken E, Meydani S. BMI-based Prenatal Vitamins to Ameliorate Oxidative Stress in Obese Pregnant Women: A Randomized Controlled Trial (P11-135-19). Curr Dev Nutr. 2019 Jun; 3(Suppl 1).

2. Ferguson KK, Rosario Z, McElrath TF, Vélez Vega C, Cordero JF, Alshawabkeh A, Meeker JD. Demographic risk factors for adverse birth outcomes in Puerto Rico in the PROTECT cohort. PLoS One. 2019; 14(6):e0217770.

3. Darling AM, Werler MM, Cantonwine DE, Fawzi WW, McElrath TF. Timing and amount of gestational weight gain in association with adverse birth outcomes. Epidemiology. 2019 Jun 10.

4. Darling AM, Werler MM, Cantonwine DE, Fawzi WW, McElrath TF. Accuracy of a mixed effects model interpolation technique for the estimation of pregnancy weight values. J Epidemiol Community Health. 2019 May 31.

5. De Tina A, Juang J, McElrath TF, Baty JD, Palanisamy A. Oxytocin and Oxytocinase in the Obese and Nonobese Parturients during Induction and Augmentation of Labor. AJP Rep. 2019 Apr; 9(2):e177-e184.

6. Ferguson KK, Cantonwine DE, McElrath TF, Mukherjee B, Meeker JD. Corrigendum to "Repeated measures analysis of associations between urinary bisphenol-A concentrations and biomarkers of inflammation and oxidative stress in pregnancy" [Reprod. Toxicol. 66 (2016) 93-98]. Reprod Toxicol. 2019 May 21.

7. Kamai EM, McElrath TF, Ferguson KK. Fetal growth in environmental epidemiology: mechanisms, limitations, and a review of associations with biomarkers of non-persistent chemical exposures during pregnancy. Environ Health. 2019 May 08; 18(1):43.

8. Mirzakhani H, Carey VJ, McElrath TF, Hollis BW, O'Connor GT, Zeiger RS, Bacharier L, Litonjua AA, Weiss ST. Maternal Asthma, Preeclampsia and Risk of Childhood Asthma at Age Six. Am J Respir Crit Care Med. 2019 May 06.

9. MacDonald SC, McElrath TF, Hernández-Díaz S. Use and safety of disease-modifying therapy in pregnant women with multiple sclerosis. Pharmacoepidemiol Drug Saf. 2019 Apr; 28(4):556-560.

10. Ferguson KK, McElrath TF, Mukherjee B, Loch-Caruso R, Meeker JD. Correction: Associations between Maternal Biomarkers of Phthalate Exposure and Inflammation Using Repeated Measurements across Pregnancy. PLoS One. 2019; 14(2):e0212958.